342
Human Polyomavirus JC Crosses in vitro Blood-Brain-Barrier by Infecting Human Brain Microvascular Endothelial Cells
Moti Chapagain*, T Nguyen, S Verma, and V Nerurkar
Univ of Hawaii, Honolulu, US
Background: In the HAART era, progressive
multifocal leukoencephalopathy (PML), remains an important cause of morbidity
and mortality among AIDS patients. The pathogenesis of PML, specifically how JC
virus (JCV), the etiological agent of PML, crosses the blood-brain barrier (BBB)
remains unclear. We hypothesized that cell-free JCV during viremia may infect
the human brain microvascular endothelial cells (HBMVEC), a critical component
of the BBB and cross the BBB to further infect other brain cells, specifically,
oligodendrocytes.
Methods: Primary HBMVEC were infected with JCV (Mad1) and were
analyzed for the expression of early viral protein, T antigen (TAg), by reverse
transcriptase real-time PCR. An in vitro
BBB model was developed to study the transmigration of cell-free JCV across the
BBB by seeding primary human brain cortical astrocytes and primary HBMVEC, on
the lower and upper surfaces, respectively, of fibronectin-coated, 3-μm
pore, 24-well format cell culture inserts. Moreover, the effect of several
serotonin inhibitors including chlorpromazine, kentaserin, and ritanserin in
blocking the JCV infection of HBMVEC or its transmigration across the BBB model
was tested.
Results: Expression of TAg in JCV-infected HBMVEC
increased 2- to 4-fold from day 5 to day 10 post-infection, and serotonin
blockers were unable to inhibit JCV infection. About 1% of the JCV inoculated
in the upper chamber was recovered from the lower chamber supernatant by day 7
post-inoculation, whereas only 0.2% of the heat-inactivated JCV crossed the BBB
by day 7. Moreover, 90% of the heat-inactivated JCV recovered from the lower
chamber crossed the BBB within the first 6 hour; in contrast 85% of JCV crossed
the BBB after the first 6 hours, with a gradual increase till 148 hours. The
serotonin inhibitors did not block JCV transmigration across the in vitro BBB model.
Conclusions: Our data indicates that cell-free JCV can
infect the HBMVEC, JCV can migrate across the BBB, and based on the infection
of primary human fetal glial cells, the migrated JCV is infectious. The transmigration of
JCV was slow in early hours post-infection but continued to increase slowly and
gradually over the next 7 days. Inability of the heat-inactivated JCV to
continue to cross the BBB after 6 hours indicates that infectious JCV is
essential to efficiently cross the BBB. Moreover, JCV does not employ serotonin
receptors to infect HBMVEC, nor to cross the BBB, and serotonin blockers may
not prevent the spread of JCV to brain cells.
|